0001487371-21-000075.txt : 20210222 0001487371-21-000075.hdr.sgml : 20210222 20210222190457 ACCESSION NUMBER: 0001487371-21-000075 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210218 FILED AS OF DATE: 20210222 DATE AS OF CHANGE: 20210222 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: O'Brien Scott Alexander CENTRAL INDEX KEY: 0001805551 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34753 FILM NUMBER: 21662281 MAIL ADDRESS: STREET 1: 5964 LA PLACE COURT CITY: CARLSBAD STATE: CA ZIP: 92008 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GenMark Diagnostics, Inc. CENTRAL INDEX KEY: 0001487371 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 272053069 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5964 LA PLACE COURT CITY: CARLSBAD STATE: CA ZIP: 92008 BUSINESS PHONE: (760) 448-4300 MAIL ADDRESS: STREET 1: 5964 LA PLACE COURT CITY: CARLSBAD STATE: CA ZIP: 92008 4 1 wf-form4_161403865922256.xml FORM 4 X0306 4 2021-02-18 0 0001487371 GenMark Diagnostics, Inc. GNMK 0001805551 O'Brien Scott Alexander 5964 LA PLACE COURT SAN DIEGO CA 92008 0 1 0 0 SVP, Global Mktg & Int'l Sales Common Stock 2021-02-18 4 A 0 37500 0 A 182465 D Market Stock Units 0.0 2021-02-18 4 A 0 12500 0 A Common Stock 12500.0 12500 D The amount reported reflects restricted stock units granted to the Reporting Person pursuant to the Issuer's 2020 Equity Incentive Plan. The restricted stock units vest 25% on February 18, 2022 and the remaining shares subject to such award vest in 12 equal quarterly installments thereafter. Each market stock unit ("MSU") represents the contingent right to receive, following vesting, between 0% and 200% of one share of the Issuer's common stock, subject to the level of achievement of applicable performance conditions. The resulting number of shares acquired upon vesting of the MSUs, if any, is based on the Issuer's total shareholder return for each performance period as compared to the Nasdaq Composite Index. The MSUs vest in three equal installments, on each of December 31, 2021, December 31, 2022, and December 31, 2023; provided that, at the end of the second and third performance periods, the Reporting Person is eligible to receive any shares that were not earned in the first and second performance periods to the extent that the Issuer's two-year or three-year total shareholder return, as applicable, exceeds the prior performance results as compared to the NASDAQ Composite Index. /s/ Eric Stier, Attorney-in-fact 2021-02-22